KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Debt: 2010-2024

Historic Total Debt for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $663.7 million.

  • Emergent BioSolutions' Total Debt rose 0.20% to $663.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $663.1 million, marking a year-over-year increase of 0.20%. This contributed to the annual value of $663.7 million for FY2024, which is 48.65% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Total Debt of $663.7 million as of FY2024, which was up 48.65% from $446.5 million recorded in FY2023.
  • Over the past 5 years, Emergent BioSolutions' Total Debt peaked at $841.0 million during FY2020, and registered a low of $446.5 million during FY2023.
  • In the last 3 years, Emergent BioSolutions' Total Debt had a median value of $448.5 million in 2022 and averaged $519.6 million.
  • Per our database at Business Quant, Emergent BioSolutions' Total Debt plummeted by 44.59% in 2022 and then spiked by 48.65% in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Total Debt stood at $841.0 million in 2020, then declined by 3.76% to $809.4 million in 2021, then tumbled by 44.59% to $448.5 million in 2022, then dropped by 0.45% to $446.5 million in 2023, then surged by 48.65% to $663.7 million in 2024.